John Bluth | SVP, IR and Corporate Communications |
Jon Stonehouse | CEO |
Anthony Doyle | CFO |
Charlie Gayer | Chief Commercial Officer |
Dr. Bill Sheridan | Chief Medical Officer |
Megan Sniecinski | Chief Business Officer |
Dr. Helen Thackray | Chief R&D Officer |
Jessica Fye | JP Morgan |
Liisa Bayko | Evercore ISI |
Ken Cacciatore | Cowen & Co |
Serge Belanger | Needham & Company |
Kenny Chan | Jefferies |
Brian Abrahams | RBC Capital Markets |
Tazeen Ahmad | Bank of America |
Swapnil Wagle | Barclays |
Jonathan Wolleben | JMP Securities |
Ladies and gentlemen, thank you for standing by, and welcome to the BioCryst's First Quarter 2021 Earnings Call. Please note that today's call is being recorded. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to hand the conference over to your speaker today, Mr.